Dry AMD & GA IME Platform: Understanding Emerging Treatment Approaches for dry AMD and Geographic Atrophy

1 September, 13:15 – 14:15 CEST

Hall 3

Chairperson(s): F. Holz GERMANY

View Details

Management of diabetic macular edema: Bridging the real-world efficacy gap

1 September, 13:15 – 14:15 CEST

Hall 4

Chairperson(s): A. Loewenstein ISRAEL & L. Kodjikian FRANCE

View Details

Photobiomodulation Preclinical Mechanisms to Clinical Application: US Pivotal LIGHTSITE III Trial Results in Intermediate dry AMD Patients

1 September, 13:15 – 14:15 CEST

Hall G1

Chairperson(s): M. Munk AUSTRIA

View Details

DME Treatment Fundamentals IME Platform: Improving Visual Outcomes in DME Patients with Current and Emerging Treatments

2 September, 09.45 - 10.45 CEST

Hall 3

Chairperson(s):
R. Schlingemann NETHERLANDS

View Details

Recent Advances in Multimodal Imaging and Artificial intelligence in Ophthalmology

2 September, 09.45 - 10.45 CEST

Hall G1

Chairperson(s):
S. Srinivas USA

View Details

Smaller, Faster, Closer - Precision in Retina Surgeries

2 September, 09.45 - 10.45 CEST

Hall G2

Chairperson(s):
F. Patelli ITALY

View Details

UWF Multimodal Imaging and Microperimetry – Enhancing the Bridge between Structure and Function

2 September, 09.45 - 10.45 CEST

Hall X1

Chairperson(s):
R. Abreu Gonzalez SPAIN

View Details

Heidelberg AppWay: Secure workflow solution for access to ophthalmic applications and AI algorithms

2 September, 13.45 - 14.45 CEST

Hall E

Chairperson(s): C. Mody UK

View Details

Advancing the management of nAMD: Latest clinical insights from targeting Ang-2/VEGF-A via dual inhibition

2 September, 13.45 - 14.45 CEST

Hall 3

Chairperson(s):
F. Holz GERMANY

View Details

How LASER has changed since coronavirus struck ?

2 September, 13.45 - 14.45 CEST

Hall X1

Chairperson(s):
V. Chong UK

View Details

Reducing the burden of DME – what matters in clinical management?

2 September, 13.45 - 14.45 CEST

Hall G1

Chairperson(s):
A. Loewenstein ISRAEL

View Details

Benefits beyond vision: 10 years of delivering outcomes that matter

2 September, 13.45 - 14.45 CEST

Hall 4

Chairperson(s):
A. Stahl GERMANY

View Details

Evolving Management in Diabetic Macula Edema

2 September, 13.45 - 14.45 CEST

Hall G2

Chairperson(s):
D. Zur ISRAEL,
M. Iglicki ARGENTINA

View Details

OCTA-A Innovations: deeper, wider, and beyond Ophthalmology TBC

2 September, 13.45 - 14.45 CEST

Hall X2

Chairperson(s): M. Munk SWITERLAND

View Details

Expert clinical insights: How continuous delivery of anti-VEGF is changing the management of nAMD

2 September, 17.45 - 18.45 CEST

Hall X2

Chairperson(s):
A. Wolf GERMANY

View Details

EVA NEXUS™: The Future of Ophthalmic Surgery

2 September, 18.15 - 19.15 CEST

Hall G1

Chairperson(s):
G. Pertile ITALY

View Details

MicroPulse® and PASCAL® in the world of retinal treatments

3 September, 09.45 - 10.45 CEST

Hall E

Chairperson(s):
S. Vujosevic ITALY

View Details

Durability across indications: Seeing from the patient's perspective

3 September, 09:45 - 10:45 CEST

Hall 4

Chairperson(s):
G. Cheung SINGAPORE &
V. Chaudhary CANADA

View Details

A vision of the future: The next level in patient care